KUALA LUMPUR: Twenty months after sofosbuvir, the generic Hepatitis C drug was brought into Malaysia through compulsory licensing, only some 4,500 patients have been treated, says the Health Ministry.
It admitted that this initial stage of setting the stage for screening and treatment had been saddled with many challenges.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
